{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:43:57Z","timestamp":1794631437976,"version":"4.9.1"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":117,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.reth.2024.09.014","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T16:50:05Z","timestamp":1730307005000},"page":"981-989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Application of mesenchymal stem cells for neurodegenerative diseases therapy discovery"],"prefix":"10.1016","volume":"26","author":[{"given":"Quynh Dieu","family":"Trinh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huynh Nhu","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5794-6882","authenticated-orcid":false,"given":"Duc Toan","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.reth.2024.09.014_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000509268","article-title":"Mesenchymal stem cells: a potential therapeutic strategy for neurodegenerative diseases","volume":"83","author":"Yao","year":"2020","journal-title":"Eur Neurol"},{"issue":"10","key":"10.1016\/j.reth.2024.09.014_bib2","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41593-018-0237-7","article-title":"Converging pathways in neurodegeneration, from genetics to mechanisms","volume":"21","author":"Gan","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.reth.2024.09.014_bib3","series-title":"Neuropsychology of movement disorders and motor neuron disease: Parkinson\u2019s disease, progressive supranuclear palsy, essential tremor, Huntington\u2019s disease, and amyotrophic lateral sclerosis BT - handbook of medical neuropsychology: applications of cogni","first-page":"415","author":"Tr\u00f6ster","year":"2019"},{"key":"10.1016\/j.reth.2024.09.014_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136107","article-title":"A\u00a0novel method based on matching pursuit decomposition of gait signals for Parkinson's disease, Amyotrophic lateral sclerosis and Huntington's disease detection","volume":"761","author":"Saljuqi","year":"2021","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.reth.2024.09.014_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cnr.2006.09.006","article-title":"Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease","volume":"6","author":"Lee Mosley","year":"2006","journal-title":"Clin Neurosci Res"},{"issue":"3","key":"10.1016\/j.reth.2024.09.014_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.reth.2024.09.014_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12020517","article-title":"Oxidative stress and antioxidants in neurodegenerative disorders","volume":"12","author":"Olufunmilayo","year":"2023","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl Neurodegener"},{"issue":"11","key":"10.1016\/j.reth.2024.09.014_bib9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41419-019-2091-2","article-title":"Mitochondrial damage by \u03b1-synuclein causes cell death in human dopaminergic neurons","volume":"10","author":"Ganjam","year":"2019","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11064-017-2318-5","article-title":"Role of mitochondria in methamphetamine-induced dopaminergic neurotoxicity: involvement in oxidative stress, neuroinflammation, and pro-apoptosis\u2014a review","volume":"43","author":"Shin","year":"2018","journal-title":"Neurochem Res"},{"issue":"2","key":"10.1016\/j.reth.2024.09.014_bib11","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/med.21712","article-title":"Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: finding ways for prevention","volume":"41","author":"Angelova","year":"2021","journal-title":"Med Res Rev"},{"issue":"7113","key":"10.1016\/j.reth.2024.09.014_bib12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.reth.2024.09.014_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2525967","article-title":"Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications","volume":"2017","author":"Liu","year":"2017","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"10.1016\/j.reth.2024.09.014_bib14","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1023\/A:1025682611389","article-title":"Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases","volume":"28","author":"Rego","year":"2003","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/ijms22010138","article-title":"Challenges in biomaterial-based drug delivery approach for the treatment of neurodegenerative diseases: opportunities for extracellular vesicles","volume":"22","author":"Kumar","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.reth.2024.09.014_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/17425240902758188","article-title":"Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases","volume":"6","author":"Barchet","year":"2009","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.reth.2024.09.014_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00139","article-title":"Pharmacological modulation of functional phenotypes of microglia in neurodegenerative diseases","volume":"9","author":"Song","year":"2017","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"10.1016\/j.reth.2024.09.014_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson's disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.reth.2024.09.014_bib19","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4155\/fmc.12.123","article-title":"Neurodegenerative diseases: challenges and opportunities","volume":"4","author":"Cuny","year":"2012","journal-title":"Future Med Chem"},{"issue":"5","key":"10.1016\/j.reth.2024.09.014_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biopsych.2012.11.021","article-title":"The circadian system in Alzheimer's disease: disturbances, mechanisms, and opportunities","volume":"74","author":"Coogan","year":"2013","journal-title":"Biol Psychiatr"},{"issue":"2","key":"10.1016\/j.reth.2024.09.014_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0748730410395732","article-title":"Circadian clock gene expression in brain regions of alzheimer \u2019s disease patients and control subjects","volume":"26","author":"Cermakian","year":"2011","journal-title":"J\u00a0Biol Rhythm"},{"key":"10.1016\/j.reth.2024.09.014_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nbscr.2016.11.001","article-title":"Circadian dysregulation in Parkinson's disease","volume":"2","author":"Videnovic","year":"2017","journal-title":"Neurobiol sleep circadian Rhythm"},{"issue":"12","key":"10.1016\/j.reth.2024.09.014_bib23","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrneurol.2014.206","article-title":"\u2019The clocks that time us\u2019\u2014circadian rhythms in neurodegenerative disorders","volume":"10","author":"Videnovic","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.reth.2024.09.014_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.627330","article-title":"Circadian and sleep dysfunctions in neurodegenerative disorders\u2014an update","volume":"14","author":"Fifel","year":"2021","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13287-022-02878-0","article-title":"The circadian clock has roles in mesenchymal stem cell fate decision","volume":"13","author":"Gao","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.reth.2024.09.014_bib26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.stem.2020.05.002","article-title":"Circadian regulation of adult stem cell homeostasis and aging","volume":"26","author":"Benitah","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.reth.2024.09.014_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/stem.269","article-title":"Mesenchymal stromal cells: current understanding and clinical status","volume":"28","author":"Salem","year":"2010","journal-title":"Stem Cell"},{"issue":"6","key":"10.1016\/j.reth.2024.09.014_bib28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1634\/stemcells.19-6-477","article-title":"Stem cells from the mammalian blastocyst","volume":"19","author":"Rossant","year":"2001","journal-title":"Stem Cell"},{"issue":"4","key":"10.1016\/j.reth.2024.09.014_bib29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.reth.2024.09.014_bib30","series-title":"Chapter 58 - applications of stem cells in developmental toxicology","first-page":"783","author":"Hansen","year":"2011"},{"key":"10.1016\/j.reth.2024.09.014_bib31","series-title":"The tumorigenicity of human embryonic stem cells","first-page":"133","author":"Blum","year":"2008"},{"issue":"3","key":"10.1016\/j.reth.2024.09.014_bib32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/er.2008-0031","article-title":"Ethical issues in stem cell research","volume":"30","author":"Lo","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.reth.2024.09.014_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00908","article-title":"Adult stem cells and induced pluripotent stem cells for stroke treatment","volume":"10","author":"Fern\u00e1ndez-Susavila","year":"2019","journal-title":"Front Neurol"},{"issue":"7","key":"10.1016\/j.reth.2024.09.014_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41576-019-0100-z","article-title":"Induced pluripotent stem cells in disease modelling and drug discovery","volume":"20","author":"Rowe","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.reth.2024.09.014_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.reth.2020.11.006","article-title":"iPSC for modeling neurodegenerative disorders","volume":"15","author":"Valadez-Barba","year":"2020","journal-title":"Regen Ther"},{"issue":"7607","key":"10.1016\/j.reth.2024.09.014_bib36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/534310a","article-title":"How iPS cells changed the world","volume":"534","author":"Scudellari","year":"2016","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.reth.2024.09.014_bib37","article-title":"iPSCs in neurodegenerative disorders: a unique platform for clinical research and personalized medicine","volume":"12","author":"Pandey","year":"2022","journal-title":"J\u00a0Personalized Med"},{"issue":"13","key":"10.1016\/j.reth.2024.09.014_bib38","doi-asserted-by":"crossref","DOI":"10.1097\/00001756-200009110-00035","article-title":"Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation","volume":"11","author":"Chopp","year":"2000","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.reth.2024.09.014_bib39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system","volume":"12","author":"Le Blanc","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","article-title":"Mesenchymal stem cells: mechanisms of inflammation","volume":"6","author":"Singer","year":"2011","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"10.1016\/j.reth.2024.09.014_bib41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2014.02.013","article-title":"Mesenchymal stem\/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis","volume":"143","author":"Bronckaers","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.reth.2024.09.014_bib42","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.reth.2024.09.014_bib43","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/stem.2614","article-title":"Concise review: MSC adhesion cascade\u2014insights into homing and transendothelial migration","volume":"35","author":"Nitzsche","year":"2017","journal-title":"Stem Cell"},{"key":"10.1016\/j.reth.2024.09.014_bib44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.isci.2019.05.004","article-title":"Mesenchymal stromal cell homing: mechanisms and strategies for improvement","volume":"15","author":"Ullah","year":"2019","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.reth.2024.09.014_bib45","doi-asserted-by":"crossref","DOI":"10.1227\/01.NEU.0000125007.03145.00","article-title":"Preclinical evaluation of a novel intracerebral microinjection instrument permitting electrophysiologically guided delivery of therapeutics","volume":"54","author":"Cunningham","year":"2004","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1016\/j.reth.2024.09.014_bib46","first-page":"1189","article-title":"Intravenous mesenchymal stem cell therapy for traumatic brain injury: laboratory investigation","volume":"110","author":"Harting","year":"2009","journal-title":"J\u00a0Neurosurg JNS"},{"key":"10.1016\/j.reth.2024.09.014_bib47","article-title":"MSCs: delivery routes and engraftment, cell-targeting strategies, and immune modulation","volume":"2013","author":"Kean","year":"2013","journal-title":"Stem Cell Int"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib48","article-title":"Neuroinflammation induces neurodegeneration","volume":"1","author":"Kempuraj","year":"2016","journal-title":"J\u00a0Neurol Neurosurg spine"},{"issue":"3","key":"10.1016\/j.reth.2024.09.014_bib49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","article-title":"Inflammation in neurodegenerative disease\u2014a double-edged sword","volume":"35","author":"Wyss-Coray","year":"2002","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.reth.2024.09.014_bib50","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/35094583","article-title":"Cytokines and acute neurodegeneration","volume":"2","author":"Allan","year":"2001","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"10.1016\/j.reth.2024.09.014_bib51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0197-0186(96)00078-2","article-title":"CYTOKINE-MEDIATED neuronal apoptosis","volume":"30","author":"Hu","year":"1997","journal-title":"Neurochem Int"},{"issue":"4","key":"10.1016\/j.reth.2024.09.014_bib52","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/01.STR.26.4.676","article-title":"Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats","volume":"26","author":"Yamasaki","year":"1995","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.reth.2024.09.014_bib53","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1046\/j.1460-9568.1998.00136.x","article-title":"Interleukin-1\u03b2 and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat","volume":"10","author":"Lawrence","year":"1998","journal-title":"Eur J Neurosci"},{"issue":"6","key":"10.1016\/j.reth.2024.09.014_bib54","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.STR.28.6.1233","article-title":"Tumor necrosis factor-\u03b1","volume":"28","author":"Barone","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.reth.2024.09.014_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121529","article-title":"GABAB receptor activation alters astrocyte phenotype changes induced by trimethyltin via ERK signaling in the dentate gyrus of mice","volume":"319","author":"Hwang","year":"2023","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","article-title":"The secretion profile of mesenchymal stem cells and potential applications in treating human diseases","volume":"7","author":"Han","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"issue":"5","key":"10.1016\/j.reth.2024.09.014_bib57","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.4049\/jimmunol.0902023","article-title":"Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression","volume":"184","author":"Ren","year":"2010","journal-title":"J\u00a0Immunol"},{"issue":"20","key":"10.1016\/j.reth.2024.09.014_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011187","article-title":"Application of mesenchymal stem cells in targeted delivery to the brain: potential and challenges of the extracellular vesicle-based approach for brain tumor treatment","volume":"22","author":"Do","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.reth.2024.09.014_bib59","first-page":"1657","article-title":"Mesenchymal stem cell-derived exosomes regulate microglia phenotypes: a promising treatment for acute central nervous system injury","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen Res"},{"issue":"12","key":"10.1016\/j.reth.2024.09.014_bib60","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.4103\/1673-5374.339489","article-title":"Exosomes derived from bone marrow mesenchymal stem cells inhibit neuroinflammation after traumatic brain injury","volume":"17","author":"Wen","year":"2022","journal-title":"Neural Regen Res"},{"issue":"5","key":"10.1016\/j.reth.2024.09.014_bib61","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s11064-020-02998-0","article-title":"MSCs-derived exosomes attenuate acute brain injury and inhibit microglial inflammation by reversing CysLT2R-ERK1\/2 mediated microglia M1 polarization","volume":"45","author":"Zhao","year":"2020","journal-title":"Neurochem Res"},{"key":"10.1016\/j.reth.2024.09.014_bib62","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2147\/JIR.S349572","article-title":"Regulatory role of mesenchymal stem cells on secondary inflammation in spinal cord injury","volume":"15","author":"Pang","year":"2022","journal-title":"J\u00a0Inflamm Res"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"3","key":"10.1016\/j.reth.2024.09.014_bib64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.reth.2024.09.014_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1178588","article-title":"Alzheimer's disease: a mini-review for the clinician","volume":"14","author":"Madnani","year":"2023","journal-title":"Front Neurol"},{"issue":"10","key":"10.1016\/j.reth.2024.09.014_bib66","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/acschemneuro.0c00052","article-title":"Mesenchymal stem cells could Be considered as a candidate for further studies in cell-based therapy of Alzheimer's disease via targeting the signaling pathways","volume":"11","author":"Farahzadi","year":"2020","journal-title":"ACS Chem Neurosci"},{"issue":"17","key":"10.1016\/j.reth.2024.09.014_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201903809","article-title":"HGF mediates clinical-grade human umbilical cord-derived mesenchymal stem cells improved functional recovery in a senescence-accelerated mouse model of Alzheimer's disease","volume":"7","author":"Jia","year":"2020","journal-title":"Adv Sci"},{"key":"10.1016\/j.reth.2024.09.014_bib68","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbr.2016.12.021","article-title":"Human umbilical cord mesenchymal stem cells transplantation improves cognitive function in Alzheimer's disease mice by decreasing oxidative stress and promoting hippocampal neurogenesis","volume":"320","author":"Cui","year":"2017","journal-title":"Behav Brain Res"},{"issue":"8","key":"10.1016\/j.reth.2024.09.014_bib69","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s11064-017-2226-8","article-title":"Amniotic mesenchymal stem cells decrease A\u03b2 deposition and improve memory in APP\/PS1 transgenic mice","volume":"42","author":"Zheng","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1016\/j.reth.2024.09.014_bib70","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2018.12.034","article-title":"Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer's disease rats","volume":"1710","author":"Hu","year":"2019","journal-title":"Brain Res"},{"key":"10.1016\/j.reth.2024.09.014_bib71","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbr.2017.10.032","article-title":"Resveratrol promotes hUC-MSCs engraftment and neural repair in a mouse model of Alzheimer's disease","volume":"339","author":"Wang","year":"2018","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.reth.2024.09.014_bib72","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s11011-019-00421-4","article-title":"Melatonin-pretreated adipose-derived mesenchymal stem cells efficeintly improved learning, memory, and cognition in an animal model of Alzheimer's disease","volume":"34","author":"Nasiri","year":"2019","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.reth.2024.09.014_bib73","article-title":"Therapeutic effects of melatonin-treated bone marrow mesenchymal stem cells (BMSC) in a rat model of Alzheimer's disease","volume":"108","author":"Ramezani","year":"2020","journal-title":"J\u00a0Chem Neuroanat"},{"issue":"6","key":"10.1016\/j.reth.2024.09.014_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9060594","article-title":"Mesenchymal stem cell-derived exosomes ameliorate Alzheimer's disease pathology and improve cognitive deficits","volume":"9","author":"Chen","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib75","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41420-021-00471-7","article-title":"Human adipose tissue-derived mesenchymal stem cells and their extracellular vesicles modulate lipopolysaccharide activated human microglia","volume":"7","author":"Garcia-Contreras","year":"2021","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.reth.2024.09.014_bib76","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41419-020-2490-4","article-title":"Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis","volume":"11","author":"Wei","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67460-1","article-title":"Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer's disease model by increasing the expression of microRNA-146a in hippocampus","volume":"10","author":"Nakano","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib78","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s11658-022-00359-z","article-title":"Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects","volume":"27","author":"Rahbaran","year":"2022","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"10.1016\/j.reth.2024.09.014_bib79","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trci.2015.06.007","article-title":"Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase 1 clinical trial","volume":"1","author":"Kim","year":"2015","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib80","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","article-title":"Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial","volume":"13","author":"Kim","year":"2021","journal-title":"Alzheimer's Res Ther"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib81","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib82","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/mds.24051","article-title":"Toward a redefinition of Parkinson's disease","volume":"27","author":"Stern","year":"2012","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib83","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41536-020-00106-y","article-title":"Challenges and translational considerations of mesenchymal stem\/stromal cell therapy for Parkinson's disease","volume":"5","author":"Fri\u010dov\u00e1","year":"2020","journal-title":"npj Regen Med"},{"issue":"7","key":"10.1016\/j.reth.2024.09.014_bib84","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s12272-021-01341-7","article-title":"Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease","volume":"44","author":"Shin","year":"2021","journal-title":"Arch Pharm Res (Seoul)"},{"key":"10.1016\/j.reth.2024.09.014_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110761","article-title":"Protein kinase C\u03b4 mediates methamphetamine-induced dopaminergic neurotoxicity in mice via activation of microsomal epoxide hydrolase","volume":"133","author":"Shin","year":"2019","journal-title":"Food Chem Toxicol"},{"issue":"6","key":"10.1016\/j.reth.2024.09.014_bib86","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/term.2081","article-title":"Mesenchymal stromal SB623 cell implantation mitigates nigrostriatal dopaminergic damage in a mouse model of Parkinson's disease","volume":"11","author":"Tate","year":"2017","journal-title":"J\u00a0Tissue Eng Regen Med"},{"issue":"4","key":"10.1016\/j.reth.2024.09.014_bib87","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1582-4934.2010.01068.x","article-title":"Endometrial stem cell transplantation restores dopamine production in a Parkinson's disease model","volume":"15","author":"Wolff","year":"2011","journal-title":"J\u00a0Cell Mol Med"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2009.09.003","article-title":"Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease","volume":"216","author":"Chao","year":"2009","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.reth.2024.09.014_bib89","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neulet.2014.10.039","article-title":"Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats","volume":"584","author":"Suzuki","year":"2015","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.reth.2024.09.014_bib90","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41419-020-2473-5","article-title":"Exosomes derived from mesenchymal stem cells repair a Parkinson's disease model by inducing autophagy","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.reth.2024.09.014_bib91","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.14336\/AD.2020.1221","article-title":"MSC-derived exosomes can enhance the angiogenesis of human brain MECs and show therapeutic potential in a mouse model of Parkinson's disease","volume":"12","author":"Xue","year":"2021","journal-title":"Aging Dis"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib92","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"10.1016\/j.reth.2024.09.014_bib93","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/14653240701376413","article-title":"Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice","volume":"9","author":"Zhao","year":"2007","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.reth.2024.09.014_bib94","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nbd.2008.05.016","article-title":"Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis","volume":"31","author":"Vercelli","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.reth.2024.09.014_bib95","article-title":"Mesenchymal stem cells: a potential therapeutic approach for amyotrophic lateral sclerosis?","volume":"2019","author":"Gugliandolo","year":"2019","journal-title":"Stem Cell Int"},{"issue":"10","key":"10.1016\/j.reth.2024.09.014_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12101389","article-title":"Pathogenesis of Huntington's disease: an emphasis on molecular pathways and prevention by natural remedies","volume":"12","author":"Irfan","year":"2022","journal-title":"Brain Sci"},{"issue":"2","key":"10.1016\/j.reth.2024.09.014_bib97","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbr.2010.11.006","article-title":"Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes","volume":"217","author":"Rossignol","year":"2011","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.reth.2024.09.014_bib98","doi-asserted-by":"crossref","first-page":"e9347","DOI":"10.1371\/journal.pone.0009347","article-title":"Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease","volume":"5","author":"Snyder","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.reth.2024.09.014_bib99","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/mt.2016.12","article-title":"Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in Huntington's disease mouse models","volume":"24","author":"Pollock","year":"2016","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.reth.2024.09.014_bib100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1474-4422(18)30461-7","article-title":"Association between circadian rhythms and neurodegenerative diseases","volume":"18","author":"Leng","year":"2019","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.reth.2024.09.014_bib101","first-page":"2275","article-title":"The sleep and circadian problems of Huntington's disease: when, why and their importance","volume":"268","author":"Voysey","year":"2021","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.reth.2024.09.014_bib102","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fneur.2018.00218","article-title":"Circadian rhythm dysfunction accelerates disease progression in a mouse model with amyotrophic lateral sclerosis","volume":"9","author":"Huang","year":"2018","journal-title":"Front Neurol"},{"issue":"12","key":"10.1016\/j.reth.2024.09.014_bib103","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1172\/JCI70317","article-title":"Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration","volume":"123","author":"Musiek","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"6315","key":"10.1016\/j.reth.2024.09.014_bib104","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.aah4968","article-title":"Mechanisms linking circadian clocks, sleep, and neurodegeneration","volume":"354","author":"Musiek","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.reth.2024.09.014_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112313","article-title":"GPx-1-encoded adenoviral vector attenuates dopaminergic impairments induced by methamphetamine in GPx-1 knockout mice through modulation of NF-\u03baB transcription factor","volume":"154","author":"Sharma","year":"2021","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.reth.2024.09.014_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111945","article-title":"Glutathione peroxidase-1 and neuromodulation: novel potentials of an old enzyme","volume":"148","author":"Sharma","year":"2021","journal-title":"Food Chem Toxicol"},{"issue":"9","key":"10.1016\/j.reth.2024.09.014_bib107","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/sctm.19-0446","article-title":"The emerging antioxidant paradigm of mesenchymal stem cell therapy","volume":"9","author":"Stavely","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.reth.2024.09.014_bib108","doi-asserted-by":"crossref","first-page":"RRN1189","DOI":"10.1371\/currents.RRN1189","article-title":"Identifying sleep disturbances in Huntington's disease using a simple disease-focused questionnaire","volume":"2","author":"Goodman","year":"2010","journal-title":"PLoS Curr"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib109","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","article-title":"Disintegration of the sleep-wake cycle and circadian timing in huntington's disease","volume":"25","author":"Morton","year":"2005","journal-title":"J\u00a0Neurosci"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nbd.2011.07.016","article-title":"The methamphetamine-sensitive circadian oscillator is dysfunctional in a transgenic mouse model of Huntington's disease","volume":"45","author":"Cuesta","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"693","key":"10.1016\/j.reth.2024.09.014_bib111","doi-asserted-by":"crossref","first-page":"eade6285","DOI":"10.1126\/scitranslmed.ade6285","article-title":"Sleep deprivation exacerbates microglial reactivity and A\u03b2 deposition in a TREM2-dependent manner in mice","volume":"15","author":"Parhizkar","year":"2023","journal-title":"Sci Transl Med"},{"issue":"150","key":"10.1016\/j.reth.2024.09.014_bib112","doi-asserted-by":"crossref","first-page":"150ra122","DOI":"10.1126\/scitranslmed.3004291","article-title":"Disruption of the sleep-wake cycle and diurnal fluctuation of \u03b2-amyloid in mice with Alzheimer's disease pathology","volume":"4","author":"Roh","year":"2012","journal-title":"Sci Transl Med"},{"issue":"6429","key":"10.1016\/j.reth.2024.09.014_bib113","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aav2546","article-title":"The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans","volume":"363","author":"Holth","year":"2019","journal-title":"Science"},{"issue":"48","key":"10.1016\/j.reth.2024.09.014_bib114","doi-asserted-by":"crossref","first-page":"10255 LP","DOI":"10.1523\/JNEUROSCI.0275-18.2018","article-title":"Chronic sleep disruption advances the temporal progression of tauopathy in P301S mutant mice","volume":"38","author":"Zhu","year":"2018","journal-title":"J\u00a0Neurosci"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-018-0241-0","article-title":"Extracellular \u03b1-synuclein levels are regulated by neuronal activity","volume":"13","author":"Yamada","year":"2018","journal-title":"Mol Neurodegener"},{"issue":"10","key":"10.1016\/j.reth.2024.09.014_bib116","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.molmed.2020.03.012","article-title":"Cell-to-Cell transmission of tau and \u03b1-synuclein","volume":"26","author":"Uemura","year":"2020","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib117","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41420-022-00908-7","article-title":"Clock-modified mesenchymal stromal cells therapy rescues molecular circadian oscillation and age-related bone loss via miR142-3p\/Bmal1\/YAP signaling axis","volume":"8","author":"Cha","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.reth.2024.09.014_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137139","article-title":"Exosomes rich in Wnt5 improved circadian rhythm dysfunction via enhanced PPAR\u03b3 activity in the 6-hydroxydopamine model of Parkinson's disease","volume":"802","author":"Li","year":"2023","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib119","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12974-017-0866-x","article-title":"YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by \u03b2-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2","volume":"14","author":"Li","year":"2017","journal-title":"J\u00a0Neuroinflammation"},{"issue":"2","key":"10.1016\/j.reth.2024.09.014_bib120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11064-014-1377-0","article-title":"PPAR\u03b3 and PGC-1\u03b1 as therapeutic targets in Parkinson's","volume":"40","author":"Corona","year":"2015","journal-title":"Neurochem Res"},{"issue":"3","key":"10.1016\/j.reth.2024.09.014_bib121","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13311-013-0187-4","article-title":"Developing therapeutic antibodies for neurodegenerative disease","volume":"10","author":"Yu","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"28","key":"10.1016\/j.reth.2024.09.014_bib122","doi-asserted-by":"crossref","first-page":"9677 LP","DOI":"10.1523\/JNEUROSCI.4742-11.2012","article-title":"An effector-reduced anti-\u03b2-amyloid (A\u03b2) antibody with unique A\u03b2 binding properties promotes neuroprotection and glial engulfment of A\u03b2","volume":"32","author":"Adolfsson","year":"2012","journal-title":"J\u00a0Neurosci"},{"issue":"4","key":"10.1016\/j.reth.2024.09.014_bib123","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jalz.2011.09.224","article-title":"Safety and biomarker effects of solanezumab in patients with Alzheimer's disease","volume":"8","author":"Farlow","year":"2012","journal-title":"Alzheimer's Dementia"},{"issue":"2","key":"10.1016\/j.reth.2024.09.014_bib124","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archneurol.2011.1538","article-title":"Mechanism of amyloid removal in patients with alzheimer disease treated with gantenerumab","volume":"69","author":"Ostrowitzki","year":"2012","journal-title":"Arch Neurol"},{"issue":"39","key":"10.1016\/j.reth.2024.09.014_bib125","doi-asserted-by":"crossref","first-page":"34457","DOI":"10.1074\/jbc.M111.229633","article-title":"Passive immunization with anti-tau antibodies in two transgenic models: reduction of tau pathology and delay of disease progression","volume":"286","author":"Chai","year":"2011","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.reth.2024.09.014_bib126","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","article-title":"Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain","volume":"118","author":"Boutajangout","year":"2011","journal-title":"J\u00a0Neurochem"},{"issue":"6","key":"10.1016\/j.reth.2024.09.014_bib127","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","article-title":"Effects of \u03b1-synuclein immunization in a mouse model of Parkinson's disease","volume":"46","author":"Masliah","year":"2005","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.reth.2024.09.014_bib128","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40265-023-01858-9","article-title":"Anti-amyloid monoclonal antibodies are transformative treatments that redefine Alzheimer's disease therapeutics","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.reth.2024.09.014_bib129","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.3390\/ijms22126442","article-title":"Brain disposition of antibody-based therapeutics: dogma, approaches and perspectives","volume":"22","author":"Kouhi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.reth.2024.09.014_bib130","first-page":"311","article-title":"Engineering antibody and protein therapeutics to cross the blood\u2013brain barrier","volume":"5","author":"Zhao","year":"2022","journal-title":"Antib Ther"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib131","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Niewoehner","year":"2014","journal-title":"Neuron"},{"issue":"545","key":"10.1016\/j.reth.2024.09.014_bib132","doi-asserted-by":"crossref","first-page":"eaay1359","DOI":"10.1126\/scitranslmed.aay1359","article-title":"Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys","volume":"12","author":"Kariolis","year":"2020","journal-title":"Sci Transl Med"},{"issue":"84","key":"10.1016\/j.reth.2024.09.014_bib133","doi-asserted-by":"crossref","first-page":"84ra44","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.reth.2024.09.014_bib134","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s13287-022-03212-4","article-title":"Mesenchymal stem cell-derived exosomes as a new therapeutic strategy in the brain tumors","volume":"13","author":"Ghasempour","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.reth.2024.09.014_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030618","article-title":"Recent advances in the application of mesenchymal stem cell-derived exosomes for cardiovascular and neurodegenerative disease therapies","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.reth.2024.09.014_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.797359","article-title":"Advances in mesenchymal stem cell-derived exosomes as drug delivery vehicles","volume":"9","author":"Rao","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"10.1016\/j.reth.2024.09.014_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020289","article-title":"Mesenchymal stem cell (MSC)-Based drug delivery into the brain across the blood\u2013brain barrier","volume":"16","author":"Tashima","year":"2024","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.reth.2024.09.014_bib138","doi-asserted-by":"crossref","first-page":"e1046","DOI":"10.1002\/ctm2.1046","article-title":"Monoclonal antibody-mediated immunosuppression enables long-term survival of transplanted human neural stem cells in mouse brain","volume":"12","author":"McGinley","year":"2022","journal-title":"Clin Transl Med"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320424001755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320424001755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T11:00:41Z","timestamp":1732964441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320424001755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":138,"alternative-id":["S2352320424001755"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2024.09.014","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of mesenchymal stem cells for neurodegenerative diseases therapy discovery","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2024.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier BV on behalf of The Japanese Society for Regenerative Medicine.","name":"copyright","label":"Copyright"}]}}